Mergers & Acquisitions
Sep. 8, 2016
Fenwick advises on $4 billion life sciences deal
Cepheid's sale to the Danaher holding company compliments an existing health care diagnostics portfolio.
Daily Journal Staff Writer
Cepheid Inc., a Sunnyvale-based maker of a molecular diagnostic technology, has agreed to a $4 billion sale to Danaher Corp. with guidance from Fenwick & West LLP.
Kirkland & Ellis LLP is advising Danaher, a multi-billion dollar holding company based in Washington, D.C.
Douglas N. Cogen in San Francisco is leading the Fenwick deal team. He could not be reached for ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In